Since IL-6 is a potent proinflammatory cytokine and NF-κB activation is considered an essential mechanism of inflammation, we investigated whether IL-6-stimulated LCN2 is related to the NF-κB pathway in human CRC cells. Here, IL6 is linked to colorectal carcinoma.